about
The role of chemotherapy in microsatellite unstable (MSI-H) colorectal cancerOutcomes following repair of traumatic cloacal deformities.Nonelective excisional colorectal surgery in English National Health Service Trusts: a study of outcomes from Hospital Episode Statistics Data between 1996 and 2007.Identification of subgroup-specific miRNA patterns by epigenetic profiling of sporadic and Lynch syndrome-associated colorectal and endometrial carcinoma.Forty-Year Analysis of Colonoscopic Surveillance Program for Neoplasia in Ulcerative Colitis: An Updated Overview.Multimodal treatment of perianal fistulas in Crohn's disease: seton versus anti-TNF versus advancement plasty (PISA): study protocol for a randomized controlled trialMolecular pathways in colorectal cancer.Systematic review: the combined surgical and medical treatment of fistulising perianal Crohn's disease.European evidence based consensus on surgery for ulcerative colitis.Oncological outcomes of local excision compared with radical surgery after neoadjuvant chemoradiotherapy for rectal cancer: a systematic review and meta-analysis.Mesenteric Infarction: Clinical Outcomes After Restoration of Bowel Continuity.Mortality after acute primary mesenteric infarction: a systematic review and meta-analysis of observational studies.Restoring TGFbeta function in microsatellite unstable (MSI-H) colorectal cancer reduces tumourigenicity but increases metastasis formation.5-fluorouracil (5FU) treatment does not influence invasion and metastasis in microsatellite unstable (MSI-H) colorectal cancer.Concomitant colonic disease (Montreal L3) and re-resectional surgery are predictors of clinical recurrence following ileocolonic resection for Crohn's disease.Laparoscopically assisted vs. open elective colonic and rectal resection: a comparison of outcomes in English National Health Service Trusts between 1996 and 2006.A new instrumental platform for Trans-Anal Submucosal Endoscopic Resection (TASER).Expression of S100A2 calcium-binding protein predicts response to pancreatectomy for pancreatic cancer.A health-related quality-of-life study comparing Vitala continence control device versus traditional pouch system only in patients with end colostomy.Rectal endoscopic submucosal dissection made easy: a solution to the retraction problem.Towards the safe introduction of transanal total mesorectal excision: the role of a clinical registry.Determining Predictors for Intra-abdominal Septic Complications Following Ileocolonic Resection for Crohn's Disease-Considerations in Pre-operative and Peri-operative Optimisation Techniques to Improve Outcome.Response to: Consensus on ventral rectopexy: report of a panel of experts.Serum elastase in the diagnosis of acute pancreatitis: a prospective studyLoss of special AT-rich sequence-binding protein 1 (SATB1) predicts poor survival in patients with colorectal cancerTransanal submucosal endoscopic resection: a new endosurgical approach to the resection of giant rectal lesionsGenetic variants and response to cancer treatmentsProbiotics and cancer: ready for meal time?Issues surrounding postoperative therapy in Crohn's disease to prevent recurrenceThe Association of Coloproctology of Great Britain and Ireland consensus guidelines in surgery for inflammatory bowel diseaseSystematic review with meta-analysis: IBD-associated colonic dysplasia prognosis in the videoendoscopic era (1990 to present)
P50
Q28274343-A0642259-3F41-46FE-AB8D-EDAD700A9E62Q33443295-6F35CF74-3AED-4F29-BDD2-FE045F6A3B87Q33546916-E140FD07-8913-4572-8CB3-F1EE44236D7AQ35169860-EC97BD3B-D002-4A3E-BB35-5656C497694AQ35896390-0843DB68-2296-445E-9E0F-8199223ED4C3Q35986231-6CD72300-ABF8-49D9-B20D-34515F231EDBQ38018369-10088CF1-80DE-4E05-A7A6-017C590669FDQ38239165-DC262370-3CA6-4257-9015-1B57720A9D23Q38258954-3033F710-C2B1-46D9-ADFB-9A50DA46C436Q38264771-F8B114B9-DA32-4A24-953D-244C81A183BEQ38309237-61BA0834-59DA-441C-9A2B-0ABAC1334A96Q38367686-31EF5A65-B7FC-4426-8585-27FADD24331BQ39921205-735C9659-3722-4084-9227-7F6C7005B01DQ40300448-DBBB4B09-DDE6-4BF3-8E1E-2D165582CC1DQ40623707-ABB37433-DC8B-4029-AD40-5CC70280B46BQ42642011-BFA196C5-3123-4334-AC48-26F9865FCB9EQ47694183-85ECF97E-957A-4450-AA13-551673D6C929Q47987813-F1F7287E-0F50-4200-9F53-9A27FD763F72Q48316317-76DF8AA7-E41A-4400-AF63-760D14FD137DQ48930367-6095930C-41F8-4FE6-85E4-3A93EC496CB6Q50664604-9FF20FCF-6AAB-4C62-AEEE-34A6A5F9EC97Q50996989-99DD5EBE-B412-4924-8084-A5B6B4518644Q53273433-F10990DC-1E7F-4F43-9214-78A25056171AQ57358470-D5FE6327-81CA-4AF7-9F94-DC9A20C893B3Q62582461-9A989594-2638-4982-9996-93B1AFA1D531Q85636690-57F5C3EA-DDD4-40C3-BF37-06A2EDFE681BQ86757904-92A70DEB-E330-4D8A-B1CA-50EDBBD64708Q87060860-3E5E1833-F0F1-4252-8CBB-524810C0CFDFQ87343379-2490D0B7-192F-4677-A688-3F9A6772C8BCQ90215648-FD36620B-ABC1-4F90-8585-842B2367C32FQ95310111-92C5E661-E6D6-42E2-91A9-60AAA619F398
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Janindra Warusavitarne
@ast
Janindra Warusavitarne
@en
Janindra Warusavitarne
@es
Janindra Warusavitarne
@nl
type
label
Janindra Warusavitarne
@ast
Janindra Warusavitarne
@en
Janindra Warusavitarne
@es
Janindra Warusavitarne
@nl
prefLabel
Janindra Warusavitarne
@ast
Janindra Warusavitarne
@en
Janindra Warusavitarne
@es
Janindra Warusavitarne
@nl
P106
P31
P496
0000-0002-7950-2833